v3.26.3
INVESTMENTS IN UNCONSOLIDATED ENTITIES - Summary of Condensed Financial Information Related to Unconsolidated Equity Method Joint Ventures, Assets Liabilities and Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Assets                    
Real estate $ 6,014,511   $ 6,014,511       $ 5,987,120      
Other assets 1,340,131   1,340,131       1,403,729      
Total assets 7,589,644   7,589,644       7,622,287      
Equity of:                    
Meritage 5,044,358 $ 5,287,520 5,044,358 $ 5,287,520 $ 5,057,937 $ 5,093,769 5,195,643 $ 5,269,174 $ 5,194,744 $ 5,141,573
Total liabilities and stockholders’ equity 7,589,644   7,589,644       7,622,287      
Earnings from financial services unconsolidated entities and other, net     2,941 3,133            
Unconsolidated entities                    
Equity of:                    
Earnings from financial services unconsolidated entities and other, net 3,515 $ 12,997 10,259 $ 16,064            
Equity Method Investment, Nonconsolidated Investee                    
Assets                    
Real estate 224,294   224,294       181,166      
Other assets 4,929   4,929       6,748      
Total assets 232,568   232,568       191,430      
Liabilities and equity:                    
Accounts payable and other liabilities 8,782   8,782       8,448      
Equity of:                    
Meritage [1] 63,817   63,817       57,268      
Other 159,969   159,969       125,714      
Total liabilities and stockholders’ equity 232,568   232,568       191,430      
Cash 3,345   3,345       3,516      
Cash $ 3,345   $ 3,345       $ 3,516      
[1] Balance represents Meritage’s interest, as reflected in the financial records of the respective joint ventures. This balance may differ from the balance reported in the accompanying unaudited consolidated financial statements due to the following reconciling items: (i) timing differences for revenue and distributions recognition, (ii) step-up basis and corresponding amortization, (iii) capitalization of interest on qualified assets, (iv) income deferrals as discussed in Note (2) below and (v) the cessation of allocation of losses from joint ventures in which we have previously written down our investment balance to zero and where we have no commitment to fund additional losses.